We are your drug development partner

Collaborating with virtual, small, and medium biotech and pharmaceutical companies to streamline drug development and achieve successful exit strategies, all in a cost-efficient manner



Are you Phase 2 ready?


Are you a consultant? Let's collaborate - join our network!


Contact

Accelerating the process from inception of IDEA to EXIT STRATEGY

About VJO Canada

At VJO Canada, we are dedicated to transforming the landscape of drug development. As a partner-research organization based in the heart of Montreal, we specialize in accelerating the journey of biotech companies from concept to market. Our unique approach combines expert guidance with innovative strategies, ensuring that your intellectual property reaches its full potential while aligning with your exit strategies. With a team of seasoned professionals boasting over a century of combined experience, we are committed to navigating the complexities of drug development alongside you.



Your Partner in Drug Development Success.
A hand is reaching for a capsule that is falling from the sky.

Our Services

General Consulting

Strategic planning and guidance throughout the development process

Non-Clinical Services

Design and management of preclinical studies

Global Monitoring

Oversight and onsite inspection of study-related activities and onsite visits

Regulatory Affairs

Preparation and submission of regulatory documents and compliance strategies

Scientific & Medical Writing

Clear, accurate and regulatory-compliant documentation of scientific data

PK & TK Modeling

Fully validated FDA 21 CFR Part 11 compliant NCA  Pharmacokinetic services

How We Work

We start with your end goal—be it Phase 2 readiness or market entry—and tailor the development process to efficiently achieve that milestone.

Idea & Initial Strategy

01.

Execution & Optimization

03.

Regulatory & Compliance

04.

Exit Strategy & Commercialization

05.



Planning & Risk Mapping

02.



A white triangle with a shadow on a white background.

Therapeutic Areas

Our team has experience across diverse drug classes and modalities—including gene therapies, biologics, cell therapies, and NCEs—delivering tailored regulatory and development strategies across therapeutic indications.


Our expertise spans high-demand therapeutic areas including oncology, rare diseases, cardiology, immunology, endocrinology, dermatology, and more—advancing innovation where it’s needed most.


At VJO Canada, we are more than just consultants—we are strategic partners committed to your success. Our experienced, multidisciplinary team combines scientific rigor with tailored strategies to accelerate drug development from concept to Phase 2 readiness.


Built on trust and powered by transparency, we believe that effective communication is the foundation of every successful project. We prioritize collaboration, keeping clients informed and engaged at every step.


With a proactive approach to project management, we anticipate challenges before they arise, ensuring smooth execution, cost efficiency, and timely delivery.


From global oversight to regulatory expertise, VJO Canada delivers the focus, flexibility, and foresight your program deserves.

Why VJO Canada

At VJO Canada, we are more than just consultants—we are strategic partners committed to your success.


Our experienced, multidisciplinary team combines scientific rigor with tailored strategies to accelerate drug development from concept to Phase 2 readiness.


Built on trust and powered by transparency, we believe that effective communication is the foundation of every successful project. We prioritize collaboration, keeping clients informed and engaged at every step.


With a proactive approach to project management, we anticipate challenges before they arise, ensuring smooth execution, cost efficiency, and timely delivery. From global oversight to regulatory expertise, VJO Canada delivers the focus, flexibility, and foresight your program deserves.


+100

Years of combined industry experience

across pharma, biotech and CRO sectors

>50

Successful development programs supported

80%

of Clients return for follow-on projects

90%

+ On-time project delivery rate

News & Blog

A person wearing gloves is holding a pill in their hand.
June 9, 2021
Stay tuned for expert insights on drug development, regulatory strategy, and biotech innovation—coming soon.